Improving IVF Success Rates & Utilizing AI in Fertility Health Care
Expert, Sean Tipton, discusses the current in vitro fertilization landscape and AI's potential to enhance fertility outcomes, pending sufficient payer coverage to drive clinical adoption.
EP: 1.Fostering Synergy in Fertility Care: Maximizing Payer-Provider Partnerships for Streamlined Patient Journeys
EP: 2.Holistic Fertility Management and Payer Collaboration
EP: 3.Improving IVF Success Rates & Utilizing AI in Fertility Health Care
EP: 4.Increasing Employer Coverage and Maximizing Fertility Benefits
EP: 5.Closing Payer Gaps and Improving Fertility Care Access
EP: 6.Family-Building Costs, Barriers and Dropout Rates Associated With Fertility Care
EP: 7.Fertility Preservation: Egg Freezing Versus Embryo Freezing
EP: 8.Risks of Miscarriage and Multiple Births Associated With Fertility Care
EP: 9.Denial of Coverage in Fertility Care
EP: 10.Shaping Fertility Coverage: Access, Costs & Medical Needs
EP: 11.Closing Current Gaps within Fertility Benefits and Care
EP: 12.Enhancements and Innovations in Fertility Care
EP: 13.Reshaping Perspective on Fertility Care Coverage
EP: 14.Supporting Employee Wellbeing Through Fertility Benefits
EP: 15.Strategic Investment: Fertility Benefits and Positive Employee Outcomes
EP: 16.Mitigating Risks: How Fertility Benefits Safeguard Employee Health
EP: 17.Insights on Plan Enhancements & Fertility Care Innovations
EP: 18.Fertility benefit coverage: Barriers and opportunities
This is a video synopsis/summary of a Population Health Perspectives® involving Sean Tipton.In the video, Tipton discusses exciting advances in precision reproductive medicine. He highlights growing interest in diagnosing and treating gametes (sperm and eggs) rather than embryos, which could identify and potentially fix problems before conception. Tipton also notes promise in applying artificial intelligence (AI) to embryology, specifically to improve embryo selection for transfer in in vitro fertilization (IVF). He explains that humans reproduce inefficiently, creating more embryos than used becausemany fail. Improved embryology techniques could enable fewer embryos to be made. Tipton cites diagnostic and gene editing work showing potential to eradicate diseases like sickle cell. However, he argues that for genomic precision medicine to truly advance, politicians must stop impeding reproductive medicine’s development through uneven regulation. Regarding AI, Tipton focuses on its ability to determine the best embryos to implant for healthy pregnancies. He also foresees techniques like genetic editing of sperm to prevent inheritable diseases playing a major future role. Althoughsuch applications likely will not immediately revolutionize reproduction, Tipton believes they could profoundly impact it within 15 years.
Video synopsis is AI generated and reviewed by Managed Healthcare Executive® editorial staff.
Can Lecanemab Succeed Where Aduhelm Failed?
September 28th 2022The announcement of positive phase 3 results for the investigational Alzheimer’s disease drug comes against a backdrop of Aduhelm flaming out. Both drugs are predicated on the theory that Alzheimer’s is caused by beta-amyloid deposits.
Read More
